HPV – Genotyping of human papillomavirus

Human papillomavirus (HPV) infection is considered the primary cause of invasive cervical cancer and its precursor lesions. HPV is a very common infection transmitted through genital contact, and most infected individuals are often unaware of the infection because the virus usually causes no initial symptoms.

In some individuals, symptoms may appear several weeks or months after sexual contact with an infected person. The most common signs are warts (condylomas) of various sizes and shapes in the genital area, although such changes often remain unnoticed.

How is HPV genotyping performed?

HPV genotyping is performed using molecular PCR diagnostics, which enables precise detection of the virus and identification of its genotype. The analysis includes 14 high-risk and 2 low-risk HPV genotypes, providing a detailed and reliable diagnosis.

The sample for analysis is taken by cervical or urethral swab, and the test does not require special preparation by the patient. The results are expressed as positive or negative, which facilitates further medical monitoring and decisions regarding additional diagnostics or treatment.

Why is testing important?

Early detection of HPV infection is crucial for preventing severe cervical changes. Testing is usually recommended along with the PAP test as part of routine gynecological screening, particularly for patients with abnormal findings or suspected infection.

Accurate HPV genotype identification enables the physician to:

• Assess the risk of developing precancerous or cancerous changes
• Determine the need for additional diagnostics, such as colposcopy
• Plan timely and targeted prevention

HPV genotyping at Polyclinic Atrijum

At Polyclinic Atrijum, HPV analysis is performed using modern PCR methods, with minimal discomfort and no special preparation required for the patient. Results are provided within the agreed timeframe, and patients receive clear instructions and recommendations for further medical management.